Demonstration of increased phosphorylation of BRAF and MEK proteins in patient’s tumor cell lysates [18] or inhibition of mutant-induced MEK and/or ERK phosphorylation by BRAF inhibitors in cell culture systems [19, 20] was also used to define kinase-activated mutants. Here, MAP2K7 is linked to neoplasm.